Skip to main content

Advertisement

ADVERTISEMENT

News

AmnioWrap2 - BioStem Technologies

https://www.globenewswire.com/en/news-release/2024/10/02/2956815/0/en/BioStem-Technologies-Initiates-BR-AC-DFU-101-Clinical-Trial-to-Study-BioREtain-in-Diabetic-Foot-Ulcers.html

BioStem Technologies announces the initiation of the BR-AC-DFU-101 clinical trial to evaluate BR-AC (AmnioWrap 2) vs SoC for non-healing DFUs. The study will be conducted at 10 sites across the US with an expected completion date of the end of 2025.

Advertisement

Advertisement

Advertisement